Literature DB >> 7426191

Effect of nifedipine on exercise tolerance in angina pectoris.

G R McIlwraith, P H Kidner, S Oram.   

Abstract

Nifedipine is a new antianginal drug, the calcium-antagonistic inhibitory action on excitation-contraction coupling apparently being so pronounced that, in therapeutic dosage, all other pharmacological properties are negligible. Its effect on exercise tolerance in angina was assessed by an exercise study involving 14 patients: single-stage exercise tests were chosen and the advantages of this are given. Our results suggest that the onset of action occurs after about 20 minutes, reaches a peak of activity at approximately one-half to two hours, and some effect may still be present at three hours. There was a significant improvement in exercise times with a mean rise of 50 per cent over placebo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426191      PMCID: PMC482407          DOI: 10.1136/hrt.44.3.335

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris.

Authors:  D J Coltart
Journal:  Br Heart J       Date:  1971-01

2.  Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment.

Authors:  D A Birkett; D A Chamberlain
Journal:  Br Med J       Date:  1966-08-27

3.  [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].

Authors:  A Fleckenstein; H Tritthart; H J Döring; K Y Byon
Journal:  Arzneimittelforschung       Date:  1972-01

4.  Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.

Authors:  G R Dagenais; R E Mason; G C Friesinger; C Wender; R S Ross
Journal:  Johns Hopkins Med J       Date:  1969-12

5.  [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)].

Authors:  W Vater; G Kroneberg; F Hoffmeister; H Saller; K Meng; A Oberdorf; W Puls; K Schlossmann; K Stoepel
Journal:  Arzneimittelforschung       Date:  1972-01

6.  [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].

Authors:  G Grün; A Fleckenstein
Journal:  Arzneimittelforschung       Date:  1972-02

7.  Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin.

Authors:  R E Goldstein; D R Rosing; D R Redwood; G D Beiser; S E Epstein
Journal:  Circulation       Date:  1971-05       Impact factor: 29.690

8.  Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris.

Authors:  D R Redwood; D R Rosing; R E Goldstein; G D Beiser; S E Epstein
Journal:  Circulation       Date:  1971-05       Impact factor: 29.690

9.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

10.  Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.

Authors:  A G Wilson; O G Brooke; H J Lloyd; B F Robinson
Journal:  Br Med J       Date:  1969-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.